Bryn Mawr Trust CO Takeda Pharmaceutical CO LTD Transaction History

Bryn Mawr Trust CO

  • $4.09 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025
SELL
$13.6 - $15.52 $17,122 - $19,539
-1,259 Reduced 32.2%
2,651 $38,000
Q2 2025

Jul 28, 2025
BUY
$13.71 - $15.46 $15,231 - $17,176
1,111 Added 39.69%
3,910 $60,000
Q1 2025

May 08, 2025
SELL
$12.89 - $15.19 $257 - $303
-20 Reduced 0.71%
2,799 $41,000
Q3 2024

Nov 25, 2024
BUY
$13.0 - $15.08 $36,647 - $42,510
2,819 New
2,819 $40,000

Others Institutions Holding TAK

# of Institutions
384
Shares Held
80.7M
Call Options Held
1.67M
Put Options Held
276K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email